Injectable Platelet-Rich Fibrin - A Revolution in Periodontal Regeneration

Monitha Gollapudi, Pavan Bajaj, Ranu R Oza, Monitha Gollapudi, Pavan Bajaj, Ranu R Oza

Abstract

As of a few years ago, platelet concentrates have been applied in a variety of medical and dental procedures. A notable aspect is that platelet-rich fibrin (PRF) is the most commonly utilized platelet concentrate in the field of dentistry. The most significant modification that was used over the years but had the biggest impact was injectable platelet-rich fibrin (I-PRF), which has more special properties. Additionally, the results of this I-PRF have been useful. The solid platelet-rich fibrin (PRF), which is a noticeable feature and has a low speed and duration in centrifugation, is the main advantage of I-PRF. I-PRF is primarily found in liquid form as PRF. It facilitates the quickening of increased vascularization and aids in accelerating the healing of wounds. An autologous blood concentration known as I-PRF has been known for many years. The advantage of I-PRF is that it exhibits constant release of growth factors and promotes cell migration by announcing the expression of type I collagen and transforming growth factor mRNA. The majority of the time, plastic and orthopedic operations use injectable platelet aggregates. It also reduces adverse reactions to transplanted material as compared to other grafting techniques. Additionally, it makes numerous other operations, like regenerative ones, much better options. In circumstances where it has been noticed, I-PRF is helpful and crucial in periodontics for bone regeneration and wound healing. It is therefore not difficult to predict that this fully autologous blood concentrate, which is now being utilized in numerous applications and requires little invasiveness, will become even more frequently used in the future. This review paper contains the differences between platelet-rich plasma (PRP) and PRF, the development of diverse platelets, and the use of I-PRF in periodontal therapy.

Keywords: bone regeneration; cell migration; collagen; grafting; growth factor; healing wounds; platelet concentrate; platelet-rich fibrin; platelet-rich plasma; platelets.

Conflict of interest statement

The authors have declared that no competing interests exist.

Copyright © 2022, Gollapudi et al.

References

    1. An opportunity in perio-implantology: the PRF. Choukroun J, Adda F, Schoeffler C, Vervelle A. Implantodontie. 2001;42:55–62.
    1. Blood coagulation; evidence of an antagonist to factor VI in platelet-rich human plasma. Kingsley CS. . Nature. 1954;173:723–724.
    1. Platelet-rich plasma: evidence to support its use. Marx RE. J Oral Maxillofacial surg Surg. 2004;62:489–496.
    1. Platelet concentrates for topical use: bedside device and blood transfusion technology. Quality and versatility. Borzini P, Balbo V, Mazzucco L. . Curr Pharm Biotechnol. 2012;13:1138–1144.
    1. Autologous platelet concentrate for the production of platelet gel. Jameson CA. Lab Med. 2007;38:39–42.
    1. Wound repair and regeneration. Reinke JM, Sorg H. . Eur Surg Res. 2012;49:35–43.
    1. A randomized controlled clinical study of autologous platelet rich fibrin (PRF) in combination with HA and beta-TCP or HA and beta-TCP alone for treatment of furcation defects. Dambhare A, Bhongade PV, Dhadse B, Sehdev KK, Ganji K, Thakare Z. J Hard Tissue Biol. 2019;28:185–190.
    1. Gingival depigmentation by free gingival autograft: a case series. Pakhare VV, Bajaj PP, Bhongade ML, and Shilpa BS. Dental Update. 2017;44:158–162.
    1. Plateletrich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Choukroun J, Diss A, Simonpieri A, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:56–60.
    1. A novel platelet concentrate: titanium-prepared platelet-rich fibrin. Tunalı M, Özdemir H, Küçükodacı Z, Akman S, Yaprak E, Toker H, Fıratlı E. Biomed Res Int. 2014;2014:209548.
    1. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Choukroun J, Ghanaati S. . Eur J Trauma Emerg Surg. 2018;44:87–95.
    1. Biological characterization of an injectable platelet-rich fibrin mixture consisting of autologous albumin gel and liquid platelet-rich fibrin (Alb-PRF) Fujioka-Kobayashi M, Schaller B, Mourão CFDAB, Zhang Y, Sculean A, Miron RJ. Platelets. 2021;32:74–81.
    1. Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft: technical note. Mourão CF, Valiense H, Melo ER, Mourão NB, Maia MD. Rev Col Bras Cir. 2015;42:421–423.
    1. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. Ghanaati S, Booms P, Orlowska A, et al. . J Oral Implantol. 2014;40:679–689.
    1. Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept) El Bagdadi K, Kubesch A, Yu X, et al. . Eur J Trauma Emerg Surg. 2019;45:467–479.
    1. Factors affecting the preparation, constituents, and clinical efficacy of leukocyte-and platelet-rich fibrin (L-PRF) Peck M, Hiss D, Stephen L. SADJ. 2016;71:298–302.
    1. Injectable platelet rich fibrin (I-PRF): opportunities in regenerative dentistry? Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, Choukroun J. Clin Oral Investig. 2017;21:2619–2627.
    1. Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft: technical note. Mourão CF de AB, Valiense H, Melo ER, Mourão NBMF, Maia MD-C. Rev Col Bras Cir. 2015;42:421–423.
    1. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:0–44.
    1. Application of platelet-rich fibrin and injectable platelet-rich fibrin in combination of bone substitute material for alveolar ridge augmentation - a case report. Chenchev IL, Ivanova VV, Neychev DZ, Cholakova RB. Folia Med. 2017;59:362–366.
    1. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Platelets. 2018;29:48–55.
    1. Injectable platelet rich fibrin: cell content, morphological, and protein characterization. Varela HA, Souza JC, Nascimento RM, et al. Clin Oral Investig. 2019;23:1309–1318.
    1. Effect of injectable platelet-rich fibrin on diced cartilage’s viability in rhinoplasty. Gode S, Ozturk A, Berber V, Kısmalı E. . Facial Plast Surg. 2019;35:393–396.
    1. A new approach for root surface biomodification using injectable platelet-rich fibrin (I-PRF) İzol BS, Üner DD. Med Sci Monit Int Med J Exp Clin Res. 2019;25:4744–4750.
    1. Injectable platelet-rich fibrin and microneedling for gingival augmentation in thin periodontal phenotype: A randomized controlled clinical trial. Ozsagir ZB, Saglam E, Sen Yilmaz B, Choukroun J, Tunali M. J Clin Periodontol. 2020;47:489–499.
    1. Clinical evaluation of injectable platelet-rich fibrin with connective tissue graft for the treatment of deep gingival recession defects: a controlled randomized clinical trial. Ucak Turer O, Ozcan M, Alkaya B, Surmeli S, Seydaoglu G, Haytac MC. J Clin Periodontol. 2020;47:72–80.
    1. A comparative evaluation of iliac crest bone graft with and without injectable and advanced platelet rich fibrin in secondary alveolar bone grafting for cleft alveolus in unilateral cleft lip and palate patients: a randomized prospective study. Dayashankara Rao JK, Bhatnagar A, Pandey R, et al. J Stomatol Oral Maxillofac Surg. 2021;122:241–247.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere